3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Phase 2
1
Status
Unknown
2
Completed
1
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Gastrointestinal
2
Conditions
Lymphoma
25
Small Cell Lung Carcinoma
23
Leukemia
18
Lymphoma, Large B-Cell, Diffuse
17
Lung Neoplasms
15
Precursor Cell Lymphoblastic Leukemia-Lymphoma
14
Lymphoma, Non-Hodgkin
14
Lymphoma, Extranodal NK-T-Cell
11
Hodgkin Disease
10
Leukemia, Myeloid, Acute
8
Carcinoma, Non-Small-Cell Lung
8
Ovarian Neoplasms
7
Neuroblastoma
7
Lymphoma, Mantle-Cell
7
Burkitt Lymphoma
7
Recurrence
6
Lymphoma, T-Cell, Peripheral
6
Central Nervous System Neoplasms
6
Retinoblastoma
5
Lymphoma, Large-Cell, Immunoblastic
5
Lymphohistiocytosis, Hemophagocytic
5
Breast Neoplasms
5
Testicular Neoplasms
4
Multiple Myeloma
4
Lymphoma, Follicular
4
Leukemia, Myelomonocytic, Acute
4
Leukemia, Monocytic, Acute
4
Leukemia, Megakaryoblastic, Acute
4
Leukemia, Erythroblastic, Acute
4
Teratoma
3
Interventions
Oxaliplatin
81
S 1 (combination)
55
Capecitabine
44
apatinib
32
Paclitaxel
32
Docetaxel
32
Irinotecan
27
Fluorouracil
22
Drug Therapy
21
sintilimab
20
Cisplatin
20
Leucovorin
16
Hyperthermic Intraperitoneal Chemotherapy
13
XELOX
12
Surgical Procedures, Operative
12
camrelizumab
10
Trastuzumab
10
titanium silicide
9
Tegafur
9
Nivolumab
9
Neoadjuvant Therapy
9
pembrolizumab
8
Laparoscopy
8
Gastrectomy
8
Folfox protocol
7
Chemotherapy, Adjuvant
7
toripalimab
6
tislelizumab
6
Ramucirumab
6
Gastroscopy
6
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Unknown
×
Stomach Neoplasms
×
Etoposide
×
Clear all
NCT02338518
2023-09-29
SVOSA
Jinling Hospital, China
Phase 3
Unknown
297 enrolled
NCT02949258
2016-10-31
NCT-B4
Jinling Hospital, China
Phase 2
Unknown
40 enrolled